150
Participants
Start Date
June 3, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
April 30, 2026
Metformin
Metformin will be initiated at 500 mg once daily with breakfast meal. The dose will be increased with 500 mg every week until 2 g/day is reached, distributed as 1000 mg every morning and evening, together with a meal. If the subject cannot tolerate the maximum dose (2 g/day), the maximal tolerated dose will be given. The treatment period including titration is 16 weeks.
Placebo
Participants in the placebo group will receive a placebo tablet identical to the metformin tablet
RECRUITING
The Parker Institute, Bispebjerg and Frederiksberg hospital, Copenhagen
Marius Henriksen
OTHER